Merck said its first-quarter earnings rose 7% as the drugmaker benefited from cost-cutting efforts and the divestitures of some assets, offsetting a modest revenue decline.
via WSJ.com: US Business http://ift.tt/1ixh2uN
via WSJ.com: US Business http://ift.tt/1ixh2uN
Nessun commento:
Posta un commento